CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5356.97M
Enterprise Value 3234.89M
Trailing P/E N/A
Forward P/E 1-6.91
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)13.57
Price/Book (mrq)8.69
Enterprise Value/Revenue 38.93
Enterprise Value/EBITDA 6-7.64

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin -113.93%
Operating Margin (ttm)-118.36%
Management Effectiveness
Return on Assets (ttm)-13.76%
Return on Equity (ttm)-59.68%
Income Statement
Revenue (ttm)26.31M
Revenue Per Share (ttm)0.55
Quarterly Revenue Growth (yoy)219.70%
Gross Profit (ttm)11.94M
EBITDA -30.76M
Net Income Avi to Common (ttm)-29.97M
Diluted EPS (ttm)-0.62
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)121.64M
Total Cash Per Share (mrq)2.5
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.78
Book Value Per Share (mrq)0.84
Cash Flow Statement
Operating Cash Flow (ttm)-4.78M
Levered Free Cash Flow (ttm)9.68M

Trading Information

Stock Price History
Beta 1.61
52-Week Change 3-9.59%
S&P500 52-Week Change 317.63%
52 Week High 310.80
52 Week Low 36.13
50-Day Moving Average 37.40
200-Day Moving Average 37.82
Share Statistics
Avg Vol (3 month) 3108.73k
Avg Vol (10 day) 353.71k
Shares Outstanding 548.77M
Float 20.76M
% Held by Insiders 140.76%
% Held by Institutions 150.36%
Shares Short 32.22M
Short Ratio 39.49
Short % of Float 39.14%
Shares Short (prior month) 32.28M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A